Qiagen NV

Healthcare · Diagnostics & Research

44.80$ -1.9% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Income Statement

Qiagen NV (QGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 535 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement QGEN
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	339	367	308	349	364	397	344	377	378	403	349	382	383	413	372	443	484	571	567	567	535	582	628	516	500	498	485	495	476	509	459	496	502	521	483	534	533	540	492	535	2,100
Cost of Revenue	118	138	112	124	123	136	118	123	121	138	124	136	128	134	129	148	163	198	197	198	198	209	213	184	179	180	178	183	178	193	168	462	194	188	175	199	201	223	183	195	802
Gross Profit	221	228	196	225	241	261	226	254	257	265	225	246	255	280	244	295	321	373	371	369	337	374	415	331	321	318	307	312	298	316	291	35	308	333	309	334	331	317	310	340	1,299
Research & Development	36	59	38	39	38	41	40	40	42	41	41	41	42	34	35	32	36	46	47	52	48	42	46	50	49	45	55	50	48	46	51	49	44	49	44	48	49	47	48	50	195
Selling, General & Administrative	33	41	32	50	32	75	32	49	32	29	38	36	29	25	28	24	28	32	34	31	30	33	34	33	31	32	33	29	29	28	28	29	29	28	32	31	30	33	28	30	121
Total Operating Expenses	173	221	172	202	177	218	178	200	180	176	184	186	462	200	176	414	276	218	207	208	205	201	208	209	223	213	211	207	201	205	196	263	196	214	193	212	202	163	193	208	766
Operating Income	48	7.0	24	22	64	43	48	53	77	88	41	60	-207	80	67	-119	45	156	164	161	132	173	207	122	98	105	97	105	97	111	95	-228	112	119	115	122	129	154	117	132	532
Interest Expense	9.6	11	10	11	12	17	15	16	16	20	20	18	17	18	19	17	18	17	14	14	15	12	14	14	16	15	14	13	13	12	10	11	11	11	7.3	7.6	8.2	10	11	10	39
Pre-Tax Income	38	-11	16	12	52	34	39	46	72	68	28	52	-227	69	46	109	28	256	159	150	151	165	196	116	96	106	109	102	100	119	102	-223	116	126	120	127	135	109	86	132	462
Income Tax Expense	3.2	-22	-1.2	-1.6	3.2	74	6.8	9.1	12	7.5	-1.1	7.1	-66	24	6.5	19	11	44	30	29	18	36	40	19	13	17	24	22	22	21	22	-40	18	38	29	31	4.7	1.3	18	29	53
Net Income	35	11	18	14	48	-40	32	37	60	61	30	45	-161	45	40	90	17	213	129	121	133	129	155	97	82	89	85	81	78	98	81	-183	98	88	91	96	130	108	68	103	409
EBITDA	101	56	81	80	116	104	107	116	137	139	108	132	-153	140	114	175	97	331	228	219	219	229	262	180	162	175	175	167	163	183	167	-159	178	183	171	184	277	169	148	142	736

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings